SV Health Investors, LLC Q2 2022 vs. Q3 2022 Holdings: An In-Depth Analysis

Investing in the stock market can be a daunting task, even for the most seasoned investor. With so many companies and funds to choose from, understanding the trends and changes in the market requires a thorough examination of data. One way investors track these changes is by reviewing SEC Form 13F filings.

Q2 2022 vs. Q3 2022 13F Holdings Comparison: What We Know

In this article, we’ll look at SV Health Investors, LLC's Q2 2022 vs. Q3 2022 13F holdings comparison. According to our analysis, the company invested in 4 different issuers in Q2 2022 and held the same positions in Q3 2022. Here’s a closer look at the numbers:

Bicycle Therapeutics PLC

SV Health Investors, LLC invested in 907,032 shares of Bicycle Therapeutics PLC in both Q2 2022 and Q3 2022, which accounts for 38.6% and 48.6% of the respective quarter's value. The shares' value increased from $15.2 million to $21.1 million, reflecting a 38.6% change.

Bioventus, Inc.

The company made no changes to its 1,488,596 shares of Bioventus, Inc. in Q2 and Q3 2022. The value of the shares increased marginally from $10.2 million to $10.4 million, equivalent to a 2.6% rise.

X4 Pharmaceuticals Inc.

Similarly, the company maintained its position in X4 Pharmaceuticals Inc., holding 311,490 shares in both quarters. The value of shares held increased from $0.3 million to $0.5 million, a 77.3% surge.

Asensus Surgical, Inc.

Lastly, SV Health Investors, LLC held 510,142 shares of Asensus Surgical, Inc. in Q2 and Q3 2022. The value of these shares increased from $0.2 million to $0.2 million, a 12.8% increase.

Adaptive Health Corp.

The company exited its position in Adaptive Health Corp., selling 994,079 shares in Q2 2022. The shares' value amounted to $17.9 million, which was fully liquidated in Q3 2022.

What Factors Contributed to the Changes in Holdings?

Numerous factors influence investors' buying and selling decisions, such as company financial performance, industry trends, macroeconomic conditions, and regulatory developments. However, without access to the company’s portfolio managers, we can only speculate what prompted SV Health Investors, LLC to maintain its position or exit Adaptive Health Corp.

Final Thoughts

SV Health Investors, LLC is one of many institutional investors that file SEC Form 13F with the US Securities and Exchange Commission every quarter. These filings reveal important insights into the company’s investment portfolio, showing which positions the company has bought, sold, or maintained in a given quarter. In this comparison of Q2 2022 vs. Q3 2022 holdings, we see the company held its positions in 4 issuers and exited Adaptive Health Corp. As an investor, understanding these changes is essential in making informed investment decisions.